Teams at Kriya Therapeutics, Inc.

The Associate Director leads CMC regulatory efforts, ensuring compliance with global regulations, managing submissions, and providing strategic regulatory guidance.

The Vice President, Pharmacovigilance oversees safety surveillance programs, evaluates adverse events, ensures regulatory compliance, and collaborates with teams on risk management strategies.

The Senior Director of Pharmacovigilance leads safety surveillance for gene therapy products, ensuring compliance with regulations and executing safety strategies across Kriya's portfolio.